EdgeIntelligence
EdgeIntelligence Raises $75M Series B to Transform HealthTech
Quick Facts
EdgeIntelligence Raises $75M Series B in Latest Funding Round
EdgeIntelligence has successfully closed a $75M Series B funding round, marking a significant milestone in the company's growth trajectory. The round was led by Y Combinator, with participation from Accel.
Company Overview
Founded in 2024 and headquartered in Seattle, WA, EdgeIntelligence has established itself in the HealthTech space. Leading digital health platform improving patient outcomes through AI-powered diagnostics
With a current valuation of $250M, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $75M Series B
- Valuation: $250M
- Lead Investor: Y Combinator
Future Outlook
As EdgeIntelligence moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
